SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005745
Filing Date
2016-05-10
Accepted
2016-05-10 06:22:50
Documents
93
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20160331x10q.htm 10-Q 2022547
2 EX-10.1 amph-20160331ex1019bc316.htm EX-10.1 695325
3 EX-10.2 amph-20160331ex1020a87a4.htm EX-10.2 316953
4 EX-31.1 amph-20160331ex31173c13e.htm EX-31.1 14643
5 EX-31.2 amph-20160331ex3124725ef.htm EX-31.2 14747
6 EX-32.1 amph-20160331ex32146b328.htm EX-32.1 10054
7 EX-32.2 amph-20160331ex32261a6ed.htm EX-32.2 10041
  Complete submission text file 0001558370-16-005745.txt   10733297

Data Files

Seq Description Document Type Size
8 EX-101.INS amph-20160331.xml EX-101.INS 2431509
9 EX-101.SCH amph-20160331.xsd EX-101.SCH 71924
10 EX-101.CAL amph-20160331_cal.xml EX-101.CAL 56663
11 EX-101.DEF amph-20160331_def.xml EX-101.DEF 252450
12 EX-101.LAB amph-20160331_lab.xml EX-101.LAB 500626
13 EX-101.PRE amph-20160331_pre.xml EX-101.PRE 454654
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 161633605
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences